Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404894 · ClinicalTrials.gov registry record
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
A clinical trial of Prostate Cancer, sponsored by Myriad Genetic Laboratories.
- Active
- Registry status
- 500
- Enrollment target
- 7
- Study locations
NCT04404894: Active study of Prostate Cancer, sponsored by Myriad Genetic Laboratories.
NCT04404894 is a study of Prostate Cancer that is active but no longer recruiting, run by Myriad Genetic Laboratories. The registered enrollment target is 500 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04404894, a study of Prostate Cancer, is active but no longer recruiting, sponsored by Myriad Genetic Laboratories.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 7
- Study locations
Study Summary
This registry will evaluate treatment selection for patients with newly diagnosed, localized prostate cancer following Prolaris testing. It will measure the proportion of men who initially select treatment with active surveillance, the time frame between active surveillance selection and any change in treatment, and clinical outcomes.
Conditions Studied
Study Locations (7)
Tennessee
- The Urology Group - Memphis
- Vanderbilt University Medical Center - Nashville
Alabama
- Urology Centers of Alabama - Homewood
California
- VA Long Beach Healthcare System - Long Beach
Florida
- Manatee Medical Research Institute - Bradenton
Illinois
- UroPartners, LLC - Westchester
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-04-30 |
| Est. Completion | 2029-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04404894
The ClinicalTrials.gov registry entry for NCT04404894 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The listed sponsor is Myriad Genetic Laboratories, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT04404894 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Tennessee, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT04404894 about?
NCT04404894 is a clinical study titled "Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing". This registry will evaluate treatment selection for patients with newly diagnosed, localized prostate cancer following Prolaris testing. It will measure the proportion of men who initially select treatment with active surveillance, the time frame between active surveillance selection and any change ...
What is the current status of trial NCT04404894?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2020-04-30. Estimated completion is 2029-11.
What conditions does trial NCT04404894 study?
This clinical trial studies the following conditions: Prostate Cancer.
Who is sponsoring clinical trial NCT04404894?
This trial is sponsored by Myriad Genetic Laboratories, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04404894 being conducted?
This trial has 7 study locations across Alabama, California, Florida, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.